These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 6647514)

  • 1. Leucinal inhibits brain aminopeptidase activity and potentiates analgesia induced by leu-enkephalen.
    Davis KR; Hernandez DE; Wolfenden R
    Pharmacol Biochem Behav; 1983 Nov; 19(5):791-4. PubMed ID: 6647514
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The effect of the aminopeptidase inhibitor bestatin on the enkephalin level in the rat brain].
    Beliaev NA; Kolesanova EF; Kelesheva LF; Rotanova TV; Panchenko LF
    Biull Eksp Biol Med; 1990 Nov; 110(11):474-5. PubMed ID: 2083325
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Some features of enkephalin metabolism in the rat brain after administration of bestatin].
    Beliaev NA; Kolesanova EF; Baronets VIu; Panchenko LF
    Biokhimiia; 1993 Jul; 58(7):1033-46. PubMed ID: 8364122
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Degradation of kyotorphin by a purified membrane-bound-aminopeptidase from monkey brain: potentiation of kyotorphin-induced analgesia by a highly effective inhibitor, bestatin.
    Ueda H; Ming G; Hazato T; Katayama T; Takagi H
    Life Sci; 1985 May; 36(19):1865-71. PubMed ID: 3990513
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of enkephalin degrading enzymes by metal chelating reagents.
    Altstein M; Blumberg S; Vogel Z
    Adv Biochem Psychopharmacol; 1982; 33():261-70. PubMed ID: 6751033
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of hydrolysis of [leu]enkephalin and D-ala2-[L-leu]enkephalin in rat plasma.
    Weinberger SB; Martinez JL
    J Pharmacol Exp Ther; 1988 Oct; 247(1):129-35. PubMed ID: 2902210
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of enkephalin metabolism by, and antinociceptive activity of, bestatin, an aminopeptidase inhibitor.
    Chaillet P; Marçais-Collado H; Costentin J; Yi CC; De La Baume S; Schwartz JC
    Eur J Pharmacol; 1983 Jan; 86(3-4):329-36. PubMed ID: 6572590
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Composite effects of actinonin when inhibiting enkephalin-degrading enzymes.
    Hachisu M; Hiranuma T; Shibazaki Y; Uotani K; Murata S; Aoyagi T; Umezawa H
    Eur J Pharmacol; 1987 May; 137(1):59-65. PubMed ID: 2886348
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analgesic effects of enkephalin analogs in rats.
    Katsuura G; Inouye K; Itoh S; Hsiao S
    Life Sci; 1984 Aug; 35(8):815-8. PubMed ID: 6548283
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification and characterization of aminopeptidases from Aplysia californica.
    Bawab W; Querido E; Crine P; DesGroseillers L
    Biochem J; 1992 Sep; 286 ( Pt 3)(Pt 3):967-75. PubMed ID: 1417757
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of a membrane-bound enkephalin-degrading aminopeptidase by bestatin analogs.
    Shimamura M; Hazato T; Hachisu M; Katayama T
    J Neurochem; 1984 Sep; 43(3):888-90. PubMed ID: 6431055
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of bestatin and thiorphan on [Met5]enkephalin-Arg6-Phe7-induced analgesia.
    Reggiani A; Carenzi A; Frigeni V; Della Bella D
    Eur J Pharmacol; 1984 Oct; 105(3-4):361-4. PubMed ID: 6391939
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of aminopeptidases responsible for inactivating endogenous (Met5)enkephalin in brain slices using peptidase inhibitors and anti-aminopeptidase M antibodies.
    Giros B; Gros C; Solhonne B; Schwartz JC
    Mol Pharmacol; 1986 Mar; 29(3):281-7. PubMed ID: 2869404
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of inhibition of neuropeptidases on the pain threshold of mice and rats.
    Carenzi A; Frigeni V; Reggiani A; Della Bella D
    Neuropharmacology; 1983 Nov; 22(11):1315-9. PubMed ID: 6363960
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibitors of a rat brain enkephalin aminopeptidase.
    Wagner GW; Dixon JE
    J Neurochem; 1981 Sep; 37(3):709-13. PubMed ID: 7276951
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Purification of membrane-bound aminopeptidase from rat brain: identification of aminopeptidase M.
    Gros C; Giros B; Schwartz JC
    Neuropeptides; 1985 Feb; 5(4-6):485-8. PubMed ID: 2860607
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Organophosphorus anticholinesterases do not mediate analgesia through inhibition of enkephalin degradation.
    Marchner H; Haraldsson S; Lundberg S
    Life Sci; 1986 Apr; 38(14):1317-21. PubMed ID: 3515093
    [TBL] [Abstract][Full Text] [Related]  

  • 18. alpha-aminoaldehydes: transition state analogue inhibitors of leucine aminopeptidase.
    Andersson L; Isley TC; Wolfenden R
    Biochemistry; 1982 Aug; 21(17):4177-80. PubMed ID: 7126535
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enkephalin degradation in the guinea-pig ileum: effect of aminopeptidase inhibitors, puromycin and bestatin.
    Cohen ML; Geary LE; Wiley KS
    J Pharmacol Exp Ther; 1983 Feb; 224(2):379-85. PubMed ID: 6822962
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characteristics of aminopeptidase activity from bovine brain microvessel endothelium.
    Baranczyk-Kuzma A; Audus KL
    J Cereb Blood Flow Metab; 1987 Dec; 7(6):801-5. PubMed ID: 3693437
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.